Claritek 125mg/5ml 50ml suspension is indicated in adults adolescents and children 6 months to 12 years for the treatment of the following acute and chronic infections when caused by clarithromycin susceptible organisms.
In appropriate combination with antibacterial therapeutic regimens and an appropriate ulcer healing medicinal product for the eradication of Helicobacter pylori in adult patients with H. pylori associated ulcers.
Clarithromycin 125 mg/5 ml suspension is indicated in adults, adolescents and children, 6 months to 12 years, for the treatment of the following acute and chronic infections, when caused by clarithromycin susceptible organisms.
• Infections of the upper respiratory tract such as tonsillitis/pharyngitis, as an alternative when beta lactam antibiotics are not appropriate.
• Acute otitis media in children.
• Infections of the lower respiratory tract such as community acquired pneumonia.
• Sinusitis and acute exacerbation of chronic bronchitis in adults and adolescents over 12 years of age